VIVIENNE AYOMANOR: Open Payments
NPI 1790282960 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,118 in 16 payments from 5 companies in 2025. Trend: 2023 $1,942 · 2024 $2,698 · 2025 $1,118
Food & beverage: $1,118
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 10 | $750 |
| Teva Pharmaceuticals USA, Inc. | 2 | $174 |
| Otsuka America Pharmaceutical, Inc. | 1 | $113 |
| Indivior Inc. | 2 | $67 |
| Gilead Sciences, Inc. | 1 | $14 |
Products named: INVEGA SUSTENNA, UZEDY, ABILIFY MAINTENA, SPRAVATO, SUBLOCADE.
Industry payments across CA — which companies pay providers there.
